A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune
Investigating whether the use of ALVAC with Remune may induce anti-HIV responses capable of controlling viral replication
View PublicationFiltrer par:
A CD4(+) Cell Count < 200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression
Determining the long-term impact of immunologic discordance (viral load <50 copies/mL and CD4+ count ≤200 cells/mm3) in antiretroviral-naive patients initiating combination antiretroviral therapy (cART).
View PublicationCan herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
Comparing the time from enrolment to the primary endpoint of either a CD4 cell count ≤ 350 cells/mm3 or initiation of HAART for any reason
View PublicationPolymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals
Investigating whether there is an association between HCV treatment response and SNPs of apoptosis-related genes during HIV/HCV coinfection
View PublicationFactors associated with virological suppression among HIV‐positive individuals on highly active antiretroviral therapy in a multi‐site Canadian cohort
Evaluating time to virological suppression in a cohort of individuals who started HAART
View PublicationDesign and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection
Discussing the MAINTAIN study design and methods
View PublicationAltruism motivates participation in a therapeutic HIV vaccine trial (CTN 173)
The first study examining motivation to participate in an HIV therapeutic vaccine trial of Remune and ALVAC
View PublicationHCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression
Investigating the role of programmed death‐1and T‐cell immunoglobulin and mucin domain‐containing molecule‐3 expression in T‐cell exhaustion during HCV/HIV co‐infection
View PublicationImpact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV–HCV coinfection before and after antiretroviral therapy
Examining the impact of spontaneous clearance of HCV on CD4+ T-lymphocyte count progression before and after initiation of ART in HIV–HCV coinfected adults
View Publication